Manifold MarketsKein KYCVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle Community-PrognoseJa 82.6%
Prognostiker
6
Fragetyp
binary
Methodik
Play-money forecasting platform
Quellentyp
Prognose
Marktdaten
Aktualisiert vor 16 Stunden
Veraltet29. Juni 25, 18:02 UTC31. Dez. 26, 23:59 UTC
Trends
Verwandte Märkte
Verwandte Fragen als Kontext, kein Vergleich gleichwertiger Kontrakte.
Will Retatrutide (new obesity drug) be FDA approved by the end of 2026?
Manifold MarketsWill Lantern Bioworks Lumina treatment be FDA Approved for preventing tooth decay by the end of 2026?
Manifold MarketsWill Lantern Bioworks Lumina treatment be FDA Approved for preventing tooth decay by the end of 2028?
Manifold MarketsRaniPill microneedle pill to replace injections: approved for sale by the end of 2026?
FutuurTdi-11861 (a fast-acting male contraceptive) approved for human clinical trials by the end of 2026?
FutuurOrion (a device that promises to project artificial vision into the brains of blind people) approved for sale by the end of 2027?
FutuurRegeln
This market predicts whether any myostatin inhibitor will receive regulatory approval for any condition by December 31, 2026.
- Myostatin inhibitors are being developed to treat conditions like muscular dystrophy and obesity.
- Notable candidates include Regeneron's trevogrumab and Eli Lilly's bimagrumab.
- Approval status can be verified through official regulatory agency announcements, such as those from the FDA (https://www.fda.gov/).
Offene Märkte
Regulation
POLYMARKETClarity Act (H.R.3633) signed into law in 2026?
- No+2.0pt86%
- Yes-2.0pt14%
- Gesamtvolumen
- 12,5 Mio. €
- 24h-Volumen
- 248.725,9 €
KALSHIWill the Clarity Act become law?
- Before Oct 1, 2027-14.0pt40%
- Before Jan 1, 2028-15.0pt38%
- Before Jul 1, 2027-15.0pt32%
+7 weitere Ergebnisse
POLYMARKETAnthropic IPO by which date?
- December 31,+3.0pt90%
- December 15,86%
- November 30,-1.0pt84%
+7 weitere Ergebnisse
- Gesamtvolumen
KALSHIWhen will Anthropic officially announce an IPO?
- Before Apr 1, 2027+5.0pt97%
- Before Jan 1, 2027+1.0pt96%
- Before Mar 1, 2027-1.0pt94%
+9 weitere Ergebnisse
KALSHIWhen will Tesla and SpaceX merge?
- Before 2028-2.0pt63%
- Before Apr 1, 2027-1.0pt51%
- Before May 1, 2027-5.0pt49%
+8 weitere Ergebnisse
POLYMARKETWhat will OpenAI's IPO valuation be?
- $1.25T–$1.5T20%
- $1.75T–$2.0T19.1%
- $1.5T–$1.75T18.1%
+5 weitere Ergebnisse
- Gesamtvolumen
- 96.559,7 €
- How many states will adopt data center moratoriums in 2026?
- Conference to Win the National Championship
- Will California authorize an alternative wage or other qualifying relief from goat-herder wage and overtime obligations before Oct 1, 2026?
- Which companies will officially announce an IPO this year?
- Discord IPO Closing Market Cap
- Will another state enact a data center moratorium in 2026?
- Which Senators will vote for the Clarity Act?
- Will Wyoming create a Digital Asset Authority?
- SpaceX' Market Cap end of October 2026?
- When will the Senate vote on the Clarity Act?
Häufige Fragen
- Wie stehen die aktuellen Quoten für Any myostatin inhibitor FDA approved by 2027?
- Manifold Markets bewertet Yes mit 83% (Stand: 8. September 2026).
- Wann wird Any myostatin inhibitor FDA approved by 2027 entschieden?
- Any myostatin inhibitor FDA approved by 2027 soll am 31. Dezember 2026 entschieden werden.
- Wie wird Any myostatin inhibitor FDA approved by 2027 abgerechnet?
- Manifold Markets rechnet diesen Markt wie folgt ab: This market predicts whether any myostatin inhibitor will receive regulatory approval for any condition by December 31, 2026.